Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News PMV Pharmaceuticals Inc PMVP

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It’s lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:PMVP)

No current opinion is available.

Bullboard Posts (NDAQ:PMVP)

Using technical analysis for this stock.

It is starting to show strength to the upside for shareholders of this company today
coolfooldumbguy - September 10, 2025

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP): Pioneering Precisio

http://beyondspx.com/2024/08/02/pmv-pharmaceuticals-inc-nasdaqpmvp-pioneering-precision-oncology-with-promising-pipeline/
MikeTester - August 3, 2024

Podcasts